| Literature DB >> 24894964 |
Abstract
BACKGROUND: To investigate retrospectively the clinicopathological characteristics and outcomes of young patients with large hepatocellular carcinoma after hepatectomy.Entities:
Mesh:
Year: 2014 PMID: 24894964 PMCID: PMC4049471 DOI: 10.1186/1477-7819-12-175
Source DB: PubMed Journal: World J Surg Oncol ISSN: 1477-7819 Impact factor: 2.754
Clinicopathologic features of 153 patients with large hepatocellular carcinoma
| Gender | | | |
| Female | 17 (24.2%) | 11(13.3%) | 0.196 |
| Male | 53 (75.8%) | 72(86.7%) | |
| Age (years) | 32 ± 5 | 55 ± 9 | |
| Hepatitis B status | | | |
| Negative | 9 (12.8%) | 28(33.7%) | |
| Positive | 61 (87.2%) | 55(66.3%) | |
| Capsular formation | | | |
| Presence | 32 (45.7%) | 29(34.9%) | 0.535 |
| Absence | 38 (54.3%) | 54(65.1%) | |
| Tumor number | | | |
| Single | 49(70.0%) | 60(72.3%) | 0.654 |
| Multiple | 21(30.0%) | 23(27.7%) | |
| AFP level | | | |
| Negative | 21 (30.0%) | 32(38.5%) | 0.616 |
| Positive | 49 (70.0%) | 51(61.5%) | |
| Liver cirrhosis | | | |
| Absent | 38 (54.3%) | 44(53.0%) | 0.851 |
| Present | 32 (45.7%) | 39(47.0%) | |
| Child-Pugh classification | | | |
| A | 56 (80.0%) | 73(87.9%) | 0.762 |
| B | 14 (20.0%) | 10(12.1%) | |
| Tumor size (cm) | 7.3 ± 2.1 | 7.9 ± 2.7 | 0.801 |
| Vascular invasion | | | |
| Absent | 37 (52.8%) | 49(59.0%) | 0.837 |
| Present | 33(47.2%) | 34(41.0%) | |
| BMI | | | |
| Normal weight | 55(78.6%) | 45(54.2%) | |
| Overweight/obese | 15(21.4%) | 38(45.8%) | |
P values in bold indicate statistical significance between groups. AFP, alpha-fetoprotein; BMI, body mass index.
Perioperative data
| Type of surgical resection | | | |
| Non-anatomical resection | 31(44.3%) | 36(43.4%) | 0.756 |
| Hemihepatectomy/extended hemihepatectomy | 39(55.7%) | 47(56.6%) | |
| Surgical resection margin (cm) | | | |
| ≤1 | 34(48.6%) | 39(47%) | 0.936 |
| >1 | 36(51.4%) | 44(53%) | |
| Operative time (minutes) | 188 ± 9 | 193 ± 23 | 0.673 |
| Time for inflow occlusion (minutes) | 13 ± 11 | 15 ± 13 | 0.516 |
| Blood loss (ml) | 1,196 ± 638 | 1,226 ± 768 | 0.475 |
| <1,000 | 36 (51.4%) | 39(47%) | 0.561 |
| ≥1,000 | 34 (48.6%) | 44(53%) | |
| Blood transfusion (patients) | | | |
| With | 38 (54.3%) | 53(63.9%) | 0.625 |
| Without | 32(45.7%) | 30(36.1%) | |
| Hospital mortality | 0 | 1(1.2%) | 0.543 |
| Complications | 16 (23.0%) | 19(22.9%) | 0.928 |
| Hospital stay (days) | 14 ± 5 | 16 ± 7 | 0.376 |
Postoperative complications
| | | ||
|---|---|---|---|
| Overall | 16 (23.0%) | 19 (22.9%) | 0.928 |
| Ascites | 2 (2.8%) | 1 (1.2%) | 0.326 |
| Wound infection | 2(2.8%) | 2(2.4%) | 0.657 |
| Pleural effusion | 1(1.4%) | 1(1.2%) | 0.536 |
| Pulmonary infection | 1(1.4%) | 11(13.3%) | |
| Biliary fistula | 2 (2.8%) | 1(1.2%) | 0.326 |
| Liver failure | 2(2.8%) | 1(1.2%)* | 0.326 |
| Bleeding | 6(8.6%) | 2(2.4%) | 0.084 |
*Caused postoperative death. P values shown in bold indicate statistical significance between groups.
Figure 1Cumulative overall and disease-free survival curves after hepatectomy of the young and older patients with large hepatocellular carcinoma.
Cox proportional hazard regression analyses for overall survival in young patients with large hepatocellular carcinoma after hepatectomy
| Gender | | | | | |
| Female | 17 | 1 | | 1 | |
| Male | 53 | 0.752(0.290-3.547) | 0.548 | 0.721(0.309-3.176) | 0.408 |
| Hepatitis B status | | | | | |
| Positive | 61 | 1 | | 1 | |
| Negative | 9 | 0.963(0.243-4.416) | 0.363 | 0.904(0.262-3.455) | 0.789 |
| AFP level (ng/mL) | | | | | |
| Negative | 21 | 1 | | 1 | |
| Positive | 49 | 1.006(0.561-1.012) | 0.053 | 1.069(0.972-1.108) | 0.129 |
| Number of tumors | | | | | |
| Single | 49 | 1 | | 1 | |
| Multiple | 21 | 1.351(0.739-2.146) | 0.053 | 1.683(0.460-2.373) | 0.112 |
| Liver cirrhosis | | | | | |
| Absent | 38 | 1 | | 1 | |
| Present | 32 | 1.114(1.058-2.934) | 1.137(0.866-2.798) | 0.207 | |
| Child-Pugh classification | | | | | |
| A | 56 | 1 | | 1 | |
| B | 14 | 1.237(0.762-2.387) | 0.508 | 1.119(0.428-3.946) | 0.623 |
| Vascular invasion | | | | | |
| Absent | 37 | 1 | | 1 | |
| Present | 33 | 2.112(1.037-3.896) | 2.233(1.010-4.232) | ||
| Edmondson-Steiner grade | | | | | |
| Low grade (I and II) | 34 | 1 | | 1 | |
| High grade (III and IV) | 36 | 1.560(1.087-3.331) | 1.747(1.235-3.346) | ||
| Surgical resection margin | | | | | |
| ≤1 cm | 34 | 1 | | 1 | |
| >1 cm | 36 | 1.339(0.234-3.642) | 0.743 | 1.366(0.356-2.956) | 0.375 |
| Blood loss (ml) | | | | | |
| <1,000 | 36 | 1 | | 1 | |
| ≥1,000 | 34 | 1.036(0.424-2.986) | 0.117 | 1.352(0.374-3.463) | 0.353 |
| Blood transfusion (ml) | | | | | |
| Without | 32 | 1 | | 1 | |
| With | 38 | 1.008(0.532-1.787) | 0.733 | 1.453(0.834-2.564) | 0.656 |
| Complications | | | | | |
| Absent | 54 | 1 | | 1 | |
| Present | 16 | 0.986(0.330-2.675) | 0.559 | 0.824(0.363-2.863) | 0.348 |
| BMI | | | | | |
| Normal weight | 55 | 1 | | 1 | |
| Overweight/obese | 15 | 1.006(0.687-1.331) | 0.309 | 1.250(0.909-1.671) | 0.326 |
*Number of patients. P values shown in bold indicate statistical significance between groups. AFP, alpha-fetoprotein; BMI, body mass index; HR, hazard ratio.